Stryker Corporation (SYK)
NYSE · Healthcare · Medical Devices
Stryker Corporation is a Healthcare company with a market capitalization of $127.55B, a trailing P/E ratio of 38.5, and a dividend yield of 1.09%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 30, 2026 | $1.93 | $2.27 | -15.0% |
| Q4 2025 | January 29, 2026 | $4.47 | $4.40 | +1.6% |
| Q3 2025 | October 30, 2025 | $2.22 | $2.56 | -13.3% |
| Q2 2025 | July 31, 2025 | $3.13 | $3.07 | +1.9% |
| Q1 2025 | May 1, 2025 | $2.84 | $2.73 | +4.0% |
| Q4 2024 | January 28, 2025 | $4.01 | $3.87 | +3.6% |
Other Medical Devices Stocks
Frequently Asked Questions
What is Stryker Corporation's market cap?
As of June 29, 2026, Stryker Corporation (SYK) has a market capitalization of $127.55B.
What is Stryker Corporation's P/E ratio?
Stryker Corporation trades at a trailing price-to-earnings (P/E) ratio of 38.5. Its forward P/E is 22.2.
Does Stryker Corporation pay a dividend?
Yes — Stryker Corporation pays a dividend yielding 1.09%, an annual payout of $3.44 per share.
What sector is SYK in?
Stryker Corporation is in the Healthcare sector, specifically the Medical Devices industry.
What was Stryker Corporation's revenue?
In its latest reported fiscal year (ending December 31, 2025), Stryker Corporation reported revenue of $25.12B and net income of $3.25B.
Ask your own questions about SYK
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.